Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$734M |
| 2 |
Adobe
ADBE
|
+$488M |
| 3 |
Merck
MRK
|
+$443M |
| 4 |
Tesla
TSLA
|
+$366M |
| 5 |
AGN
Allergan plc
AGN
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$682M |
| 2 |
Perrigo
PRGO
|
+$585M |
| 3 |
Gilead Sciences
GILD
|
+$556M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$432M |
| 5 |
Morgan Stanley
MS
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.29% |
| 2 | Consumer Discretionary | 15.4% |
| 3 | Communication Services | 11.3% |
| 4 | Technology | 10.76% |
| 5 | Energy | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
TripAdvisor
TRIP
$1.16B
| $307M | 0.3% |
+3,707,677
| New | +$303M |
|
77
Williams Companies
WMB
$90.2B
| $302M | 0.3% |
7,834,590
+1,346,368
| +21% | +$48.4M |
|
78
IDEX
IEX
$17B
| $293M | 0.29% |
3,971,185
-510,604
| -11% | -$35.5M |
|
79
Hain Celestial
HAIN
$66.1M
| $287M | 0.28% |
6,314,012
-677,366
| -10% | -$28M |
|
80
Carnival Corporation Ltd
CCL
$33.9B
| $286M | 0.28% |
7,127,571
+92,082
| +1% | +$3.25M |
|
81
Crown Castle
CCI
$32.4B
| $280M | 0.28% |
3,819,635
+885,384
| +30% | +$65.5M |
|
|
XLNX
82
DELISTED
Xilinx Inc
XLNX
| $275M | 0.27% |
5,991,652
+263,884
| +5% | +$11.9M |
|
|
WP
83
DELISTED
Worldpay, Inc.
WP
| $272M | 0.27% |
8,346,140
+1,615,961
| +24% | +$46.8M |
|
84
Cheniere Energy
LNG
$58.3B
| $265M | 0.26% |
6,140,505
-1,540,050
| -20% | -$61.3M |
|
|
DNR
85
DELISTED
Denbury Resources, Inc.
DNR
| $261M | 0.26% |
15,900,478
-1,998,153
| -11% | -$35.3M |
|
|
FRC
86
DELISTED
First Republic Bank
FRC
| $254M | 0.25% |
4,844,583
-54,124
| -1% | -$2.71M |
|
87
Bunge Global
BG
$22.2B
| $253M | 0.25% |
3,083,570
-425,362
| -12% | -$34.3M |
|
88
Reliance Steel & Aluminium
RS
$19.8B
| $251M | 0.25% |
3,314,230
+118,896
| +4% | +$8.79M |
|
|
INVX
89
Innovex International
INVX
$2.11B
| $241M | 0.24% |
2,190,172
+35,434
| +2% | +$4.01M |
|
90
VeriSign
VRSN
$26.4B
| $237M | 0.23% |
3,970,531
-411,070
| -9% | -$22.6M |
|
|
ATVI
91
DELISTED
Activision Blizzard
ATVI
| $232M | 0.23% |
13,026,604
+1,598,471
| +14% | +$27.5M |
|
92
Henry Schein
HSIC
$9.98B
| $232M | 0.23% |
5,172,053
-344,107
| -6% | -$15.1M |
|
93
Dollar Tree
DLTR
$24.1B
| $231M | 0.23% |
4,099,381
-21,646
| -0.5% | -$1.25M |
|
94
Microsoft
MSFT
$3.81T
| $229M | 0.22% |
6,114,994
-1,988,589
| -25% | -$72.2M |
|
95
Ross Stores
ROST
$73.3B
| $229M | 0.22% |
6,100,290
+522,244
| +9% | +$19.6M |
|
|
SEMG
96
DELISTED
SEMGROUP CORPORATION
SEMG
| $228M | 0.22% |
3,497,369
+104,236
| +3% | +$6.26M |
|
97
Flex
FLEX
$40.8B
| $228M | 0.22% |
38,948,253
-2,727,958
| -7% | -$16.6M |
|
98
Citigroup
C
$223B
| $225M | 0.22% |
4,324,888
-312,999
| -7% | -$15.8M |
|
99
Ametek
AME
$54.2B
| $225M | 0.22% |
4,265,272
-796,409
| -16% | -$38.5M |
|
100
Marathon Petroleum
MPC
$104B
| $222M | 0.22% |
4,835,992
+2,830,920
| +141% | +$109M |
|
Similar funds
Jennison Associates's Q4 2013 Portfolio in Review
As of Q4 2013, Jennison Associates held 759 positions worth $102B, up 6.9% from $95.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jennison Associates's Q4 2013 filing shows 79 new, 184 increased, 411 reduced and 54 closed positions. Its largest new stake was Allergan plc: 2,016,619 shares worth $339M. The largest sale was UnitedHealth, an estimated $682M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q4 2013 buy was Allergan plc: 2,016,619 shares worth $339M.
- Jennison Associates added most to Bristol-Myers Squibb in Q4 2013, an estimated $734M increase.
- Jennison Associates's biggest Q4 2013 reduction was UnitedHealth, cutting an estimated $682M.
- Jennison Associates fully exited Perrigo in Q4 2013, selling an estimated $585M.
- Jennison Associates's ten largest holdings make up 20% of its $102B portfolio in Q4 2013.
- Jennison Associates opened 79 new positions and closed 54 in Q4 2013.
- Jennison Associates's portfolio value rose 6.9% quarter-over-quarter to $102B.
Based on Jennison Associates's 13F filing for Q4 2013, filed 10 Feb 2014.